Authors: Michaelides, MR Dellaria, JF Gong, J Holms, JH Bouska, JJ Stacey, J Wada, CK Heyman, HR Curtin, ML Guo, Y Goodfellow, CL Elmore, IB Albert, DH Magoc, TJ Marcotte, PA Morgan, DW Davidsen, SK

Citation: Mr. Michaelides et al., Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitors, BIOORG MED, 11(12), 2001, pp. 1553-1556

Authors: Curtin, ML Florjancic, AS Heyman, HR Michaelides, MR Garland, RB Holms, JH Steinman, DH Dellaria, JF Gong, J Wada, CK Guo, Y Elmore, IB Tapang, P Albert, DH Magoc, TJ Marcotte, PA Bouska, JJ Goodfellow, CL Bauch, JL Marsch, KC Morgan, DW Davidsen, SK

Citation: Ml. Curtin et al., Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770, BIOORG MED, 11(12), 2001, pp. 1557-1560

Authors: Marcotte, PA Elmore, IN Guan, ZW Magoc, TJ Albert, DH Morgan, DW Curtin, ML Garland, RB Guo, Y Heyman, HR Holms, JH Sheppard, GS Steinman, DH Wada, CK Davidsen, SK

Citation: Pa. Marcotte et al., Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitors, J ENZ INHIB, 14(6), 1999, pp. 425-435

Authors: Sheppard, GS Florjancic, AS Giesler, JR Xu, LH Guo, Y Davidsen, SK Marcotte, PA Elmore, I Albert, DH Magoc, TJ Bouska, JJ Goodfellow, CL Morgan, DW Summers, JB

Citation: Gs. Sheppard et al., Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors, BIOORG MED, 8(22), 1998, pp. 3251-3256